Neoadjuvant Immune-Checkpoint Blockade Therapy Combined with TACE for Resectable Hepatocellular Carcinoma with High Recurrence Risk: A Phase II, Single-Arm Clinical Trial (MORNING).

Li Tan,Lixia Xu, Shun-Li Shen, Dongming Li,Yunpeng Hua, Shaoqiang Li,Lijian Liang,Qiang He, Qi Zhou, Wenxuan Xie, Zebin Chen,Jian Wu,Jiaping Li, Wenzhe Fan, Wenquan Zhuang,Lili Chen,Shiting Feng, Sui Peng,Jiping Wang,Ming Kuang

Journal of Clinical Oncology（2024）

Cited 0|Views15

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined